Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study

A. Piperata, J. Van den Eynde, M. Marin-Cuartas, G. Bortolussi, P. Fila, T. Walter, MC. Sarıcaoğlu, J. Gofus, B. Rajdeep, MP. Sá, F. Rosati, M. De la Cuesta, E. Gastino, B. Cuko, J. Ternacle, C. de Vincentiis, M. Czerny, AR. Akar, G. Lucchese, B....

. 2025 ; 67 (4) : . [pub] 20250328

Jazyk angličtina

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25016337

OBJECTIVES: Long-term evidence about bioprosthetic tricuspid valve replacement is scarce. This study aims to investigate the long-term clinical outcomes of patients who underwent tricuspid valve replacement with bioprostheses. METHODS: This multicentre retrospective study included patients from 10 high-volume centres in 7 different countries, who underwent tricuspid valve replacement with bioprostheses. Echocardiographic and clinical data were reviewed. Long-term outcomes were investigated using Kaplan-Meier estimates, Cox regression, and competing risk analysis. RESULTS: Of 675 patients, isolated tricuspid valve replacement was performed in 358 patients (53%), while 317 (47%) underwent concomitant procedures. Between these 2 groups, patients who underwent combined procedures reported a significantly higher incidence of infection, atrioventricular block, multi-organ failure, longer intensive care unit and hospital stay and higher 30-day mortality over patients who underwent isolated procedure. The overall 30-day mortality occurred in 70 patients (10.4%) [46 (14.6%) combined vs 24 (6.74%) isolated, P = 0.001]. During the follow-up, there was a continuous rate of attrition due to death, with cumulative incidences of death at 5, 10 and 15 years being 27.2%, 46.2% and 60.6%, respectively. In contrast, the risk of reintervention starts to significantly increase after 10 years of follow-up, with cumulative incidences of reintervention being 6.1%, 10.8% and 23.3%, respectively. Freedom from tricuspid valve reintervention, pacemaker implantation, tricuspid valve endocarditis and major thromboembolic events at 15 years were 56.5%, 77.3%, 84.0% and 86.4%, respectively. CONCLUSIONS: Tricuspid valve replacement with bioprostheses is an effective treatment for valvular disease, despite being associated with relatively high early and long-term mortality. However, the risk of structural valve degeneration rises significantly after 10 years.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016337
003      
CZ-PrNML
005      
20250731092838.0
007      
ta
008      
250708s2025 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ejcts/ezaf107 $2 doi
035    __
$a (PubMed)40128150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Piperata, Antonio $u Medico-Surgical Department (Valvulopathies, Cardiac Surgery, Adult Interventional Cardiology), Hôpital Cardiologique de Haut-Lévèque, Bordeaux University Hospital, Bordeaux, France $1 https://orcid.org/0000000278028586
245    10
$a Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study / $c A. Piperata, J. Van den Eynde, M. Marin-Cuartas, G. Bortolussi, P. Fila, T. Walter, MC. Sarıcaoğlu, J. Gofus, B. Rajdeep, MP. Sá, F. Rosati, M. De la Cuesta, E. Gastino, B. Cuko, J. Ternacle, C. de Vincentiis, M. Czerny, AR. Akar, G. Lucchese, B. Ramlawi, MA. Borger, T. Modine
520    9_
$a OBJECTIVES: Long-term evidence about bioprosthetic tricuspid valve replacement is scarce. This study aims to investigate the long-term clinical outcomes of patients who underwent tricuspid valve replacement with bioprostheses. METHODS: This multicentre retrospective study included patients from 10 high-volume centres in 7 different countries, who underwent tricuspid valve replacement with bioprostheses. Echocardiographic and clinical data were reviewed. Long-term outcomes were investigated using Kaplan-Meier estimates, Cox regression, and competing risk analysis. RESULTS: Of 675 patients, isolated tricuspid valve replacement was performed in 358 patients (53%), while 317 (47%) underwent concomitant procedures. Between these 2 groups, patients who underwent combined procedures reported a significantly higher incidence of infection, atrioventricular block, multi-organ failure, longer intensive care unit and hospital stay and higher 30-day mortality over patients who underwent isolated procedure. The overall 30-day mortality occurred in 70 patients (10.4%) [46 (14.6%) combined vs 24 (6.74%) isolated, P = 0.001]. During the follow-up, there was a continuous rate of attrition due to death, with cumulative incidences of death at 5, 10 and 15 years being 27.2%, 46.2% and 60.6%, respectively. In contrast, the risk of reintervention starts to significantly increase after 10 years of follow-up, with cumulative incidences of reintervention being 6.1%, 10.8% and 23.3%, respectively. Freedom from tricuspid valve reintervention, pacemaker implantation, tricuspid valve endocarditis and major thromboembolic events at 15 years were 56.5%, 77.3%, 84.0% and 86.4%, respectively. CONCLUSIONS: Tricuspid valve replacement with bioprostheses is an effective treatment for valvular disease, despite being associated with relatively high early and long-term mortality. However, the risk of structural valve degeneration rises significantly after 10 years.
650    _2
$a lidé $7 D006801
650    12
$a bioprotézy $x škodlivé účinky $7 D001705
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a retrospektivní studie $7 D012189
650    12
$a trikuspidální chlopeň $x chirurgie $7 D014261
650    _2
$a lidé středního věku $7 D008875
650    12
$a chirurgická náhrada chlopně $x mortalita $x škodlivé účinky $x metody $7 D019918
650    12
$a srdeční chlopně umělé $x škodlivé účinky $7 D006350
650    _2
$a senioři $7 D000368
650    _2
$a výsledek terapie $7 D016896
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
650    12
$a nemoci srdečních chlopní $x chirurgie $x mortalita $7 D006349
650    _2
$a dospělí $7 D000328
650    _2
$a následné studie $7 D005500
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Van den Eynde, Jef $u Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium $1 https://orcid.org/000000025606376X
700    1_
$a Marin-Cuartas, Mateo $u Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany
700    1_
$a Bortolussi, Giacomo $u Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy $1 https://orcid.org/0000000336401597
700    1_
$a Fila, Petr $u Centre of Cardiovascular Surgery and Transplantation, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Walter, Tim $u Universitatslinikum Freiburg/Standort Bad kr Krozingen, Baden-Württemberg, Freiburg, Germany
700    1_
$a Sarıcaoğlu, Mehmet Cahit $u Department of Cardiovascular Surgery, Ankara University Medical Faculty, İç Anadolu Bölgesi, Ankara, Turkey
700    1_
$a Gofus, Jan $u Department of Cardiac Surgery, Charles University, Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech Republic $1 https://orcid.org/0000000203463137
700    1_
$a Rajdeep, Bilkhu $u Cardiovascular Department, St Thomas' Hospital, London, UK
700    1_
$a Sá, Michel Pompeu $u Department of Cardiovascular Surgery, Lankenau Heart Institute, Lankenau Medical Center, Philadelphia, PA, USA
700    1_
$a Rosati, Fabrizio $u Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy $1 https://orcid.org/0000000214753156
700    1_
$a De la Cuesta, Manuela $u Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany
700    1_
$a Gastino, Elisa $u Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy
700    1_
$a Cuko, Besart $u Medico-Surgical Department (Valvulopathies, Cardiac Surgery, Adult Interventional Cardiology), Hôpital Cardiologique de Haut-Lévèque, Bordeaux University Hospital, Bordeaux, France
700    1_
$a Ternacle, Julien $u Medico-Surgical Department (Valvulopathies, Cardiac Surgery, Adult Interventional Cardiology), Hôpital Cardiologique de Haut-Lévèque, Bordeaux University Hospital, Bordeaux, France $1 https://orcid.org/0000000296295864
700    1_
$a de Vincentiis, Carlo $u Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy $1 https://orcid.org/0000000299450057
700    1_
$a Czerny, Martin $u Universitatslinikum Freiburg/Standort Bad kr Krozingen, Baden-Württemberg, Freiburg, Germany $1 https://orcid.org/0000000347669775
700    1_
$a Akar, Ahmet Rüçhan $u Department of Cardiovascular Surgery, Ankara University Medical Faculty, İç Anadolu Bölgesi, Ankara, Turkey
700    1_
$a Lucchese, Gianluca $u Cardiovascular Department, St Thomas' Hospital, London, UK
700    1_
$a Ramlawi, Basel $u Department of Cardiovascular Surgery, Lankenau Heart Institute, Lankenau Medical Center, Philadelphia, PA, USA
700    1_
$a Borger, Michael A $u Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany $1 https://orcid.org/0000000310461364
700    1_
$a Modine, Thomas $u Medico-Surgical Department (Valvulopathies, Cardiac Surgery, Adult Interventional Cardiology), Hôpital Cardiologique de Haut-Lévèque, Bordeaux University Hospital, Bordeaux, France
773    0_
$w MED00001607 $t European journal of cardio-thoracic surgery $x 1873-734X $g Roč. 67, č. 4 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40128150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092832 $b ABA008
999    __
$a ok $b bmc $g 2366893 $s 1253462
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 67 $c 4 $e 20250328 $i 1873-734X $m European journal of cardio-thoracic surgery $n Eur J Cardiothorac Surg $x MED00001607
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace